Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 458 clinical trials
Vaccination of Triple Negative Breast Cancer Patients

or III triple negative breast cancer (TNBC). This study will compare the vaccine plus standard neoadjuvant chemotherapy and surgery to standard neoadjuvant chemotherapy and surgery alone.

triple negative breast cancer
doxorubicin
mammogram
breast cancer
cyclophosphamide
  • 17 views
  • 26 Feb, 2022
  • 1 location
MicroRNA Profiles in Triple Negative Breast Cancer (TARMAC)

Triple negative breast cancer (TNBC) is an aggressive disease with higher proportion of Blacks affected and in younger age groups. There is no targeted therapy unlike other types of breast

triple negative breast cancer
taxane
doxorubicin
growth factor
carboplatin
  • 0 views
  • 23 Mar, 2022
  • 1 location
Neoadjuvant Camrelizumab Plus Chemotherapy in Triple Negative Breast Cancer

negative breast cancer (TNBC).

triple negative breast cancer
docetaxel
doxorubicin
measurable disease
mammogram
  • 0 views
  • 28 Oct, 2021
  • 1 location
Deferoxamine Plus Chemotherapy for Metastatic Triple Negative Breast Cancer

The objective of the study is to evaluate the efficacy and safety of chemotherapy plus deferoxamine in metastatic breast cancer whose evaluation is stable disease with a trend of progression.

triple negative breast cancer
measurable disease
metastasis
  • 0 views
  • 25 Apr, 2022
  • 1 location
Palbociclib and Binimetinib in Advanced Triple Negative Breast Cancer

advanced unresectable triple negative breast cancer with activation of ERK and/or CDK4/6 in which the following will be assesed: the overall response rate, the aggregation of antitumor effect depending on

triple negative breast cancer
palbociclib
mammogram
BRCA2
BRCA1
  • 0 views
  • 16 Sep, 2021
  • 8 locations
Radiation, Immunotherapy and PARP Inhibitor in Triple Negative Breast Cancer (NADiR)

This research study is looking to see whether the combination of Dostarlimab and Niraparib plus Radiation Therapy (RT) is safe and effective in participants with metastatic triple negative

triple negative breast cancer
HER2
erbb2
mammogram
  • 4 views
  • 28 Apr, 2022
  • 2 locations
Huaier Granule in Treating Women With Triple Negative Breast Cancer

Huaier Granule in treating women who have triple negative breast cancer that has been surgically removed.

platelet count
breast cancer
neutrophil count
cancer
  • 1 views
  • 21 Jan, 2021
  • 1 location
Oral Etoposide Combined With Anlotinib in Advanced Triple Negative Breast Cancer

clinical study of oral etoposide combined with antinib in the treatment of recurrent or metastatic triple-negative breast cancer

triple negative breast cancer
taxane
measurable disease
metastasis
  • 29 views
  • 02 Aug, 2021
  • 1 location
Calorie Restriction With or Without Metformin in Triple Negative Breast Cancer

Glucose starvation and metformin have synergistic antitumor effects that are mediated through the concomitant inhibition of glycolysis and mitochondrial oxidative phosphorylation. The BREAKFAST trial will evaluate the antitumor activity of combining cyclic fasting-mimicking diet (FMD), which reproduces the in vitro effects of glucose starvation, plus/minus metformin with standard preperative anthracycline-taxane …

triple negative breast cancer
bilateral oophorectomy
gilbert's syndrome
gene amplification
breast cancer
  • 34 views
  • 25 Jan, 2021
  • 1 location
PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast Cancer

This clinical study is aiming to determine the safest doses and schedule for the combination of two drugs named palbociclib and avelumab. The study will also be investigating how effective the combination is for a subgroup of breast cancer patients whose cancer expresses the androgen receptor (AR) but not the …

triple negative breast cancer
advanced breast cancer
endocrine therapy
breast cancer
erbb2
  • 1 views
  • 30 May, 2021
  • 1 location